張育嘉(Chang, Yu-Jia) 教授

Email
r5424012@tmu.edu.tw
現   職
臨床醫學研究所 教授

學經歷

學 歷

畢業學校與學位[修業時間]
國立成功大學基礎醫學研究所 博士
1998/09~2003/10
國立臺灣大學醫事技術學系 碩士
1996/09~1998/08
國立臺灣大學醫事技術學系 學士
1989/09~1994/08

本校學術經歷

任職單位與職稱[起迄時間]
臨床醫學研究所教授
2013/02/01~
臨床醫學研究所副教授
2010/02/01~2013/01/31
外科學科助理教授
2007/02/01~2010/01/31

本校兼職教學行政經歷

服務單位與職稱[起迄時間]
國際醫學研究碩士學位學程教授
2018/02/01 ~
國際醫學研究博士學位學程教授
2018/02/01 ~
(舊)細胞治療與再生醫學國際博士學位學程籌備處教授
2018/02/01 ~
國際醫學研究博士學位學程教授
2016/11/01 ~ 2017/10/31
國際醫學研究碩士學位學程教授
2016/11/01 ~ 2017/10/31
實驗動物中心主任
2011/10/01 ~ 2012/10/31

其它經歷

任職單位與職稱[起迄時間]
羅徹斯特大學pathology博士後研究
2004/11~2006/08
成功大學生化所博士後研究
2003/11~2004/10

專長與研究領域

學門領域
Molecular Biology(分生)
Protein Chemistry(蛋白質化學)
Emzymology(酵素學)
Hematology(血液學)
Cancer Biology (癌症生物學)
Biochemistry (生化學)
學術專長
Cloning
Xenograft animal model
portein expression and purification

論文著作

清冊下載


1. 2023 Lee CC,Lee AW,Wei PL,Liu YS,Chang YJ,Huang CY. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer . Sci Rep . .2023 ;(13):4366-4366

2. 2023 Lee CC,Tsai KY,Lee AW,Wei PL,Huang CY,Batzorig U, Chang YJ. CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer . Int J Mol Sci. .2023 ;(24):15262-15262

3. 2023 Tsai KY,Wei PL,Lee CC,Makondi PT,Chen HA,Chang YY, Liu DZ, Huang CY, Chang YJ. 2,3,5,4'-Tetrahydroxystilbene (TG1), a Novel Compound Derived from 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside (THSG), Inhibits Colorectal Cancer Progression by Inducing Ferroptosis, Apoptosis, and Autophagy . Biomedicines .2023 ;(11):1798-1798

4. 2023 Tsai KY,Chang YJ,Huang CY,Prince GMSH,Chen HA,Makondi PT, Shen YR, Wei PL. Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer . J Transl Med. .2023 ;(21):505

5. 2023 Huang CY,Wei PL,Batzorig U,Makondi PT,Lee CC,Chang YJ. Identification of Moesin (MSN) as a Potential Therapeutic Target for Colorectal Cancer via the β-Catenin-RUNX2 Axis . Int J Mol Sci. .2023 ;(24):10951-10951

6. 2023 Wei PL,Huang CY,Chang TC,Lin JC,Lee CC,Prince GMSH, Makondi PT, Chui AW, Chang YJ. PCTAIRE Protein Kinase 1 (PCTK1) Suppresses Proliferation, Stemness, and Chemoresistance in Colorectal Cancer through the BMPR1B-Smad1/5/8 Signaling Pathway . Int J Mol Sci. .2023 ;(24):10008-10008

7. 2023 Tsai KY,Wei PL,Azarkan M,M'Rabet N,Makondi PT,Chen HA, Huang CY, Chang YJ. Cytotoxic properties of unfractionated and fractionated bromelain alone or in combination with chemotherapeutic agents in colorectal cancer cells . PLoS One .2023 ;(18):e0285970-e0285970

8. 2023 Huang CY, ,Wei PL,Prince GMSH,Batzorig U,Lee CC,Chang YJ, Hung CS. The Role of Thrombomodulin in Estrogen-Receptor-Positive Breast Cancer Progression, Metastasis, and Curcumin Sensitivity . Biomedicines .2023 ;(11):1384-1384

9. 2023 Wei PL,Prince GMSH,Batzorig U,Huang CY,Chang YJ. ALDH2 promotes cancer stemness and metastasis in colorectal cancer through activating β-catenin signaling . J Cell Biochem .2023 ;(124):907-920

10. 2023 Chang YJ,Prince GMSH,Wei PL,Batzorig U,Huang CY,Hung CS, Chang TC. The role of thrombomodulin in modulating ITGB3 expression and its implications for triple-negative breast cancer progression . Cell Biol Int .2023 ;(48):216-228

11. 2022 Po-Li Wei,, Jang-Chun Lin,Chin-Sheng Hung,Precious Takondwa Makondi,Uyanga Batzorig,, Tung-Cheng Chang, Chien-Yu Huang, Yu-Jia Chang. Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway . International Journal of Medical Science .2022

12. 2022 Li CL,Wang CC,Pai HT,Tu SL,Hou PY,Huang CY, Huang MT, Chang YJ.. The Natural Compound Dehydrocrenatidine Attenuates Nicotine-Induced Stemness and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma by Regulating a7nAChR-Jak2 Signaling Pathways. . Dis Markers. .2022

13. 2022 A Novel IGLC2 Gene Linked With Prognosis of Triple-Negative Breast Cancer. . Front Oncol. .2022

14. 2022 Wang WL,Batzorig U,Hung CS,, Wei PL,Huang CY,Chang YJ. Aldehyde Dehydrogenase 2 Family Member (ALDH2) Is a Therapeutic Index for Oxaliplatin Response on Colorectal Cancer Therapy with Dysfunction p53. . Biomed Res Int. 2022 Feb 7; .2022

15. 2021 Huang CY,Chang YJ, Wei PL,Hung CS, Wang W. Methyl gallate, gallic acid-derived compound, inhibit cell proliferation through increasing ROS production and apoptosis in hepatocellular carcinoma cells. . PLOS ONE .2021 ;(16):e0248521.

16. 2021 Kao WY,Lin YF,Chang IW,Chen CL,Tang JH,Chang CC, Chang YJ, Wang W.. Interleukin-2 receptor alpha as a biomarker for nonalcoholic fatty liver disease diagnosis. . J Chin Med Assoc. .2021 ;(84):261-266

17. 2021 Chou CW, ,Huang YM, ,Chang YJ, ,Huang CY, ,Hung CS. Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer . Int J Med Sci .2021 ;(18):2521-2531

18. 2021 Lin CL, ,Tsai ML, ,Chen YH, ,Liu WN, ,Lin CY, ,Hsu KW, Huang CY, Chang YJ, Wei PL, Chen SH, Huang LC, Lee CH. Platelet-Derived Growth Factor Receptor-α Subunit Targeting Suppresses Metastasis in Advanced Thyroid Cancer In Vitro and In Vivo . Biomol Ther (Seoul) .2021 ;(0):0-0

19. 2021 Batzorig U, ,Wei PL, ,Wang W, ,Huang CY, ,Chang YJ. Glucose-Regulated Protein 94 Mediates the Proliferation and Metastasis through the Regulation of ETV1 and MAPK Pathway in Colorectal Cancer . Int J Med Sci .2021 ;(18):2251-2261

20. 2021 Wei PL,Hung CS,Lu HH,Batzorig U,Huang CY,Chang YJ. Areca nut extract (ANE) inhibits the progression of hepatocellular carcinoma cells via activation of ROS production and activation of autophagy. . Int J Med Sci. .2021 ;(18):3452-3462

21. 2021 Li YK,Hsu HM,Lin MC,Chang CW, ,Chu CM, ,Chang YJ, Yu JC, Chen CT, Jian CE, Sun CA, Chen KH, Kuo MH, Cheng CS, Chang YT, Wu YS, Wu HY, Yang YT, Lin C, Lin HC, Hu JM, Chang YT. Genetic co-expression networks contribute to creating predictive model and exploring novel biomarkers for the prognosis of breast cancer . Sci Rep. .2021 ;(11):7268-7268

22. 2021 PL Wei, ,JC Lin, ,CS Hung, ,PT Makondi, ,U Batzorig,,TC Chang, CY Huang, and YJ Chang . Human α-defensin 6 (HD6) suppresses CRC proliferation and metastasis through abolished EGF/EGFR signaling pathway . International Journal of Medical Science .2021

23. 2020 Kao WY, ,Chang IW, ,Chen CL, ,Su CW, ,Fang SU, ,Tang JH, Chang CC, Chang YJ, Wang W. Fibroscan-Based Score to Predict Significant Liver Fibrosis in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease . Obes Surg .2020 ;(0):00-00

24. 2020 Tai CJ,Shi YC,Tai CJ,Kuo LJ,Chen RJ,Chang YJ, Tzao C, Wu CH, Chang CC, Chiou HY, Su CH.. Taiwanofungus camphoratus Combined With Amphotericin B for Metastatic Cancer Patients Unresponsive to or Unwilling to Undergo Chemotherapy: A Pilot Study . Altern Ther Health Med. .2020 ;(26):18-22

25. 2019 Huang CY, ,Wei PL, ,Wang JW, ,Makondi PT, ,Huang MT, ,Chen HA, Chang YJ. Glucose-Regulated Protein 94 Modulates the Response of Osteosarcoma to Chemotherapy. . Dis Markers. .2019 ;(0):4569718-4569718

26. 2019 Chang TC, ,Wei PL, ,Makondi PT, ,Chen WT, ,Huang CY, ,Chang YJ. Bromelain inhibits the ability of colorectal cancer cells to proliferate via activation of ROS production and autophagy. . PLoS One .2019 ;(14):e0210274-e0210274

27. 2019 Wei PL, ,Huang CY, ,Chang YJ. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy. . PLoS One. .2019 ;(14):e0210513-e0210513

28. 2019 Makondi PT, ,Wei PL, ,Huang CY, ,Chang YJ.. Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach. . PLoS One .2019 ;(14):e0211968-e0211968

29. 2019 Hsu HM, ,Chu CM, ,Chang YJ, ,Yu JC, ,Chen CT, ,Jian CE, Lee CY, Chiang YT, Chang CW, Chang YT.. Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis. . Sci Rep. .2019 ;(9):4484-4495

30. 2019 Yu CC, ,Chen LC, ,Chiou CY, ,Chang YJ, ,Lin VC, ,Huang CY, Lin IL, Chang TY, Lu TL, Lee CH, Huang SP, Bao BY.. Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression. . Cancer Cell Int. .2019 ;(19):87

31. 2019 Hung CS, ,Huang CY, ,Hsu YW, ,Makondi PT, ,Chang WC, ,Chang YJ, Wang JY, Wei PL. . HSPB1 rs2070804 polymorphism is associated with the depth of primary tumor. . J Cell Biochem .2019

32. 2019 Li CL, ,Lin YK, ,Chen HA, ,Huang CY, ,Huang MT, ,Chang YJ. Smoking as an Independent Risk Factor for Hepatocellular Carcinoma Due to the α7-Nachr Modulating the JAK2/STAT3 Signaling Axis. . J Clin Med. .2019 ;(8):E1391-E1391

33. 2018 Makondi PT,Lee CH,Huang CY,Chu CM,Chang YJ,Wei PL. Prediction of the novel target genes and pathways involved in bevacizumab-resistant colorectal cancer . PLOS ONE .2018 ;(13):e0189582

34. 2018 WAN-LI CHENG,CHIEN-YU HUANG,CHENG-JENG TAI,YU-JIA CHANG,CHIN-SHENG HUNG. Maspin Enhances the Anti-Cancer Activity of Curcumin in Hormone-Refractory Prostate Cancer Cells . Anticancer Res. 2018 .2018 ;(2):863-870

35. 2018 Chien-Yu Huang,Chia-Hwa Lee,Chao-Chiang Tu, Chih-Hsiung Wu,MingTe Huang,Po-Li Wei and Yu-Jia Chang. Glucose-regulated protein 94 mediates progression and metastasis of esophageal squamous cell carcinoma via mitochondrial function and the NFkb/COX-2/VEGF axis . Oncotarget. .2018 ;(10):9425-9441

36. 2018 Shih CM, ,Huang CY, ,Wang KH, ,Huang CY, ,Wei PL,,Chang YJ, Hsieh CK, Liu KT, Lee AW.. Oxidized Low-Density Lipoprotein-Deteriorated Psoriasis Is Associated with the Upregulation of Lox-1 Receptor and Il-23 Expression In Vivo and In Vitro. . Int J Mol Sci. .2018 ;(9):E2610

37. 2018 Shih CM, ,Huang CY, ,Huang CY, ,Wang KH, ,Wei PL, ,Chang YJ, Fong TH, Pan JL, Lee AW.. A dipeptidyl peptidase-4 inhibitor promotes wound healing in normoglycemic mice by modulating keratinocyte activity. . Exp Dermatol. .2018

38. 2018 Kan PC, ,Chang YJ, ,Chien CS, ,Su CY, ,Fang HW.. Coupling Dichloroacetate Treatment with Curcumin Significantly Enhances Anticancer Potential. . Anticancer Res. .2018

39. 2018 Hsu KW, ,Huang CY, ,Tam KW, ,Lin CY, ,Huang LC, ,Lin CL, Hsieh WS, Chi WM, Chang YJ, Wei PL, Chen ST, Lee CH.. The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death. . Int J Mol Sci. .2018 ;(2):E452

40. 2018 Liang HH, ,Huang CY, ,Chou CW, ,Makondi PT, ,Huang MT, ,Wei PL, Chang YJ.. Heat shock protein 27 influences the anti-cancer effect of curcumin in colon cancer cells through ROS production and autophagy activation. . Life Sci. .2018

41. 2018 Huang EY, Chang YJ, Huang SP, ,Lin VC, ,Yu CC, ,Huang CY, ,Yin HL, ,Chang TY, Lu TL, Bao BY.. A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer. . J Cell Mol Med. 2018 Jul;22(7):-. doi: . .2018 ;(7):3661-3670

42. 2018 Chien-Yu Huang, Po-Li Wei ,Wei-Yu Chen,Wei-Chiao Chang ,Yu-Jia Chang. Silencing Heat Shock Protein 27 Inhibits the Progression and Metastasis of Colorectal Cancer (CRC) by Maintaining the Stability of Stromal Interaction Molecule 1 (STIM1) Proteins . Cells .2018

43. 2018 Huang CY, ,Wei PL, ,Chen WY, ,Chang WC, ,Chang YJ.. Silencing Heat Shock Protein 27 Inhibits the Progression and Metastasis of Colorectal Cancer (CRC) by Maintaining the Stability of Stromal Interaction Molecule 1 (STIM1) Proteins . Cells. .2018 ;(7):262-262

44. 2017 Hung Chin Sheng ,Huang Chien Yu ,Lee Chia Hwa ,Chen Wei Yu ,Huang Ming Te ,Wei PL, Chang YJ. IGFBP2 plays an important role in heat shock protein 27-mediated cancer progression and metastasis . Oncotarget .2017 ;(8):54978-54992

45. 2017 Makondi Precious Takondwa ,Chu Chi Ming ,Wei Po Li ,Chang Yu Jia . Prediction of novel target genes and pathways involved in irinotecan-resistant colorectal cancer . PLOS ONE .2017 ;(7):e0180616

46. 2017 Lin RK, ,Hung WY, ,Huang YF, ,Chang YJ, ,Lin CH, ,Chen WY, Chiu SF, Chang SC, Tsai SF.. Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer. . Oncotarget .2017 ;(8):113431-113443

47. 2016 Tu CC,Huang CY,Cheng WL,Hung CS,Uyanga B,Wei PL, Chang YJ.. The α7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to taxanes. . Tumor Biology .2016 ;(37):4421-4428

48. 2016 Huang CY,Batzorig U,Cheng WL,Huang MT,Chen WY,Wei PL, Chang YJ.. Glucose-regulated protein 94 mediates cancer progression via AKT and eNOS in hepatocellular carcinoma. . Tumor Biology .2016 ;(37):4295-4304

49. 2016 Huang CY, Chang YJ,Luo SD,Uyanga B,Lin FY,Tai CJ,Huang MT.. Maspin mediates the gemcitabine sensitivity of hormone-independent prostate cancer. . Tumor Biology .2016 ;(37):4075-4082

50. 2016 Tu CC,Huang CY,Cheng WL,Hung CS,Chang YJ,Wei PL. Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment. . Tumour Biol. .2016 ;(37):9493-9501

51. 2016 Chang YJ,Cheng YW,Lin RK,Huang CC,Chen WT,Ke TW, Wei PL. Thrombomodulin Influences the Survival of Patients with Non-Metastatic Colorectal Cancer through Epithelial-To-Mesenchymal Transition (EMT). . PLoS One. .2016 ;(11):e01605

52. 2016 Huang CY,Shih CM,Tsao NW,Lin YW,Shih CC,Chiang KH, Shyue SK, Chang YJ, Hsieh CK, Lin FY.. The GroEL protein of Porphyromonas gingivalis regulates atherogenic phenomena in endothelial cells mediated by upregulating toll-like receptor 4 expression. . Am J Transl Res. .2016 ;(8):384-404

53. 2016 Chien CW,Hou PC,Wu HC,Chang YL,Lin SC,Lin SC, Lin BW, Lee JC, Chang YJ, Sun HS, Tsai SJ.. Targeting TYRO3 inhibits epithelial-mesenchymal transition and increases drug sensitivity in colon cancer. . Oncogene .2016 ;(35):5872-5881

54. 2016 Tai CJ,Huang MT,Wu CH,Wang CK,Tai CJ,Chang CC, Hsieh CI, Chang YJ, Wu CJ, Kuo LJ, Wei PL, Chen RJ, Chiou HY.. Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma. . Medicine (Baltimore). .2016 ;(95):e3259

55. 2016 Tai CJ,Wang H,Wang CK,Tai CJ,Huang MT,Wu CH, Chen RJ, Kuo LJ, Wei PL, Chang YJ, Chang CC, Chiou HY, Wu CJ.. Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts. . Clin Exp Med. .2016 ;(0):0-0

56. 2016 Hsieh CL,Ma HP,Su CM,Chang YJ,Hung WY,Ho YS, Huang WJ, Lin RK. Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer. . Life Sci. .2016 ;(15):7-14

57. 2016 Luo JD,Chang YJ,Chang CM,You JF,Wei PL,Chiou CC. GeneGazer: A Toolkit Integrating Two Pipelines for Personalized Profiling and Biosignature Identification. . Cancer Genomics Proteomics. .2016 ;(13):141-150

58. 2016 Wei PL,Huang CY,Tai CJ,Batzorig U,Cheng WL,Hunag MT, Chang YJ. Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma. . Tumour Biol. .2016 ;(37):8219-8227

59. 2016 Tai CJ,Huang MT,Wu CH,Tai CJ,Shi YC,Chang CC, Chang YJ, Kuo LJ, Wei PL, Chen RJ, Chiou HY. Contrast-Enhanced Ultrasound and Computed Tomography Assessment of Hepatocellular Carcinoma after Transcatheter Arterial Chemo-Embolization: A Systematic Review. . J Gastrointestin Liver Dis. .2016 ;(25):499-507

60. 2015 Wang RC, Huang CY, P,Chen WY,Ho CT,Liu TZ,Chang YJ. Proteomic Characterization of Annexin l (ANX1) and Heat Shock Protein 27 (HSP27) as Biomarkers for Invasive Hepatocellular Carcinoma Cells. . PLoS One .2015 ;(10):013923

61. 2015 Ho CT,Chang YJ,Yang LX,Wei PL,Liu TZ,Liu JJ.. A Novel Microtubule-Disrupting Agent Induces Endoplasmic Reticular Stress-Mediated Cell Death in Human Hepatocellular Carcinoma Cells. . PLOS ONE .2015 ;(10):e01363

62. 2015 Wang CK,Lin YF,Tai CJ,Wang CW,Chang YJ,Choong CY, Lin CS, Tai CJ, Chang CC.. Integrated Treatment of Aqueous Extract of Solanum nigrum-Potentiated Cisplatin- and Doxorubicin-Induced Cytotoxicity in Human Hepatocellular Carcinoma Cells. . Evid Based Complement Alternat Med. .2015

63. 2015 Chen WY,Huang CY,Cheng WL,Hung CS,Huang MT,Tai CJ, Liu YN, Chen CL, Chang YJ.. Alpha 7-nicotinic acetylcholine receptor mediates the sensitivity of gastric cancer cells to 5-fluorouracil. . Tumor Biology .2015

64. 2015 Wang CW,Chen CL,Wang CK,Chang YJ,Jian JY,Lin CS, Tai CJ, Tai CJ.. Cisplatin-, Doxorubicin-, and Docetaxel-Induced Cell Death Promoted by the Aqueous Extract of Solanum nigrum in Human Ovarian Carcinoma Cells. . Integr Cancer Ther. .2015 ;(14):546-555

65. 2015 Wang CW,Wang CK,Chang YJ,Choong CY,Lin CS,Tai CJ, Tai CJ.. Preclinical evaluation on the tumor suppression efficiency and combination drug effects of fermented wheat germ extract in human ovarian carcinoma cells. . Evid Based Complement Alternat Med. .2015

66. 2015 Kuo LJ,Huang CY,Cheng WL,Hung CS,Wu CT,Lin FY, Chang YJ, Huang MT.. Glucose-regulated protein 78 mediates the anticancer efficacy of shikonin in hormone-refractory prostate cancer cells. . Tumor Biology .2015 ;(36):5063-5070

67. 2015 Chang YJ,Huang CY,Hung CS,Liu HH,Wei PL. Glucose-regulated protein 78 mediates the therapeutic efficacy of 17-DMAG in colon cancer cells. . Tumor Biology .2015 ;(36):4367-4376

68. 2015 Chang YJ,Chen WY,Huang CY,Liu HH,Wei PL. Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway. . Tumor Biology .2015 ;(36):1859-1869

69. 2015 Chang YJ,Huang CY,Hung CS,Chen WY,Wei PL.. GRP78 mediates the therapeutic efficacy of curcumin on colon cancer. . Tumor Biology .2015 ;(36):633-641

70. 2015 Lin FY,Huang CY,Lu HY,Shih CM,Tsao NW,Shyue SK, Lin CY, Chang YJ, Tsai CS, Lin YW, Lin SJ. The GroEL protein of Porphyromonas gingivalis accelerates tumor growth by enhancing endothelial progenitor cell function and neovascularization. . Mol Oral Microbiol. .2015 ;(30):198-216

71. 2015 Kao WY,Chao Y,Chang CC,Li CP,Su CW,Huo TI, Huang YH, Chang YJ, Lin HC, Wu JC.. Prognosis of Early-Stage Hepatocellular Carcinoma: The Clinical Implications of Substages of Barcelona Clinic Liver Cancer System Based on a Cohort of 1265 Patients. . Medicine .2015 ;(94):1929-1935

72. 2014 Tai CJ, ,Wang JW, ,Su HY, ,Tai CJ, ,Wang CK, ,Wu CT, Lien YC, Chang YJ. Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells. . Tumour Biol .2014 ;(35):403-410

73. 2014 Chang YJ,Li LT,Chen HA,Hung CS,Wei PL. Silencing survivin activates autophagy as an alternative survival pathway in HCC cells. . Tumor Biology .2014 ;(35):9957-9966

74. 2014 Lin CS,Chen PC,Wang CK,Wang CW,Chang YJ,Tai CJ, Tai CJ.. Antitumor Effects and Biological Mechanism of Action of the Aqueous Extract of the Camptotheca acuminata Fruit in Human Endometrial Carcinoma Cells. . Evid Based Complement Alternat Med. .2014 ;(0):564810-564815

75. 2014 Wang SC,Lee TH,Hsu CH,Chang YJ,Chang MS,Wang YC, Ho YS, Wen WC, Lin RK.. Antroquinonol D, isolated from Antrodia camphorata, with DNA demethylation and anticancer potential. . J Agric Food Chem. .2014 ;(62):5625-5635

76. 2014 Kuo LJ,Lin YK,Chang CC,Tai CJ,Chiou JF,Chang YJ.. Clinical outcomes of robot-assisted intersphincteric resection for low rectal cancer: comparison with conventional laparoscopy and multifactorial analysis of the learning curve for robotic surgery. . Int J Colorectal Dis. .2014 ;(29):555-562

77. 2014 Wu CT, Chang YJ,,Chen MF,Liu JJ,Wei PL,Wang W,Liu HH. Thrombomodulin mediates the migratory ability of hormone-independent prostate cancer cells through the regulation of epithelial-to-mesenchymal transition biomarkers. . Tumor Biology .2014 ;(35):6047-6054

78. 2014 Hung CS,Su HY,Liang HH,Lai CW,Chang YC,Ho YS, Wu CH, Ho JD, Wei PL, Chang YJ.. High-level expression of CXCR4 in breast cancer is associated with early distant and bone metastases . Tumor Biology .2014 ;(35):1581-1588

79. 2013 Tai CJ,Wang CK,Tai CJ,Lin YF,Lin CS,Jian JY, Chang YJ, Chang CC. Aqueous Extract of Solanum nigrum Leaves Induces Autophagy and Enhances Cytotoxicity of Cisplatin, Doxorubicin, Docetaxel, and 5-Fluorouracil in Human Colorectal Carcinoma Cells. . Evid Based Complement Alternat Med. .2013 ;(00):514719-514721

80. 2013 Kuo LJ,Hung CS,Chen WY,Chang YJ,Wei PL. Glucose-regulated protein 78 silencing down-regulates vascular endothelial growth factor/vascular endothelial growth factor receptor 2 pathway to suppress human colon cancer tumor growth. . J Surg Res. 2013 May 29 .2013 ;(13):472-4721

81. 2013 Liang HH,Wei PL,Hung CS,Wu CT,Wang W,Huang MT, Chang YJ. MicroRNA-200a/b influenced the therapeutic effects of curcumin in hepatocellular carcinoma (HCC) cells . Tumor Biology .2013 ;(34):3209-3218

82. 2013 Lai KP,Huang CK,Chang YJ,Chung CY,Yamashita S,Li L, Lee SO, Yeh S, Chang C. New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells. . Am J Pathol .2013 ;(182):460-73

83. 2013 Kuo LJ,Hung CS,Wang W,Tam KW,Lee HC,Liang HH, Chang YJ, Huang MT, Wei PL.. Intersphincteric resection for very low rectal cancer: clinical outcomes of open versus laparoscopic approach and multidimensional analysis of the learning curve for laparoscopic surgery. . J Surg Res. .2013 ;(183):524-530

84. 2013 Wu CT, Wang WC,Chen MF,Su HY,Chen WY,Wu CH,Chang YJ, Liu HH. Glucose-regulated protein 78 mediates hormone-independent prostate cancer progression and metastasis through maspin and COX-2 expression . Tumor Biology .2013 ;(1):1-1

85. 2013 Tai CJ, Wang JW,,Su HY,Tai CJ,Wang CK,Wu CT,Lien YC, Chang YJ.. Glucose-regulated protein 94 modulates the therapeutic efficacy to taxane in cervical cancer cells. . Tumor Biology .2013 ;(0):1-3

86. 2013 Wei PL,Tu CC,Chen CH,Ho YS,Wu CT,Su HY, Chen WY, Liu JJ, Chang YJ.. Shikonin Suppresses the Migratory Ability of Hepatocellular Carcinoma Cells. . J Agric Food Chem. .2013 ;(00):1-9

87. 2013 Tai CJ,Wang WC,Wang CK,Wu CH,Yang MD,Chang YJ, Jian JY, Tai CJ.. Fermented wheat germ extract induced cell death and enhanced cytotoxicity of Cisplatin and 5-Fluorouracil on human hepatocellular carcinoma cells. . Evid Based Complement Alternat Med .2013 ;(0):121725-0

88. 2013 Chen LM, Wang W,Lee JC,Chiu FH,Wu CT,Tai CJ,Wang CK, Tai CJ, Huang MT, Chang YJ. Thrombomodulin mediates the progression of epithelial ovarian cancer cells. . Tumor Biology .2013 ;(00):0-1

89. 2013 Huang HC,Chang TM,Chang YJ,Wen HY. UVB irradiation regulates ERK1/2- and p53-dependent thrombomodulin expression in human keratinocytes. . PLOS ONE .2013 ;(8):e67632-e67641

90. 2013 Hung CS, ,Liu HH, ,Liu JJ, ,Yeh CT, ,Chang TC, ,Wu CH, Ho YS, Wei PL, Chang YJ. MicroRNA-200a and -200b mediated hepatocellular carcinoma cell migration through the epithelial to mesenchymal transition markers. . Ann Surg Oncol. .2013 ;(20 ):S360-S368

91. 2012 Tai CJ,Chen HA,Chin-Sheng Hung,Kuo LJ,Wei PL,Lu HH,Liu TZ, Liu JJ, Liu DZ, Ho YS, Wu CH, Chang YJ. Survivin-Mediated Cancer Cell Migration Through GRP78 and Epithelial-Mesenchymal Transition (EMT) Marker Expression in Mahlavu Cells. . Annals of surgical oncology .2012 ;(19):336-343

92. 2012 Wei PL,Kuo LJ,Wang W,Lin FY,Liu HH,How T, Ho YS, Huang MT, Wu CH, Chang YJ.. Silencing of Glucose-Regulated Protein 78 (GRP78) Enhances Cell Migration Through the Upregulation of Vimentin in Hepatocellular Carcinoma Cells . Ann Surg Oncol. .2012 ;(19):572-579

93. 2012 Wang W,Chin-Sheng H,Kuo LJ,Wei PL,Lien YC,Lin FY, Liu HH, Ho YS, Wu CH, Chang YJ.. NNK Enhances Cell Migration through α7-nicotinic Acetylcholine Receptor Accompanied by Increased of Fibronectin Expression in Gastric Cancer. . Ann Surg Oncol. .2012 ;(19):580-588

94. 2012 Kuo LJ,Chiou JF,Tai CJ,Chang CC,Kung CH,Lin SE, Hung CS, Wang W, Tam KW, Lee HC, Liang HH, Chang YJ, Wei PL. Can we predict pathologic complete response before surgery for locally advanced rectal cancer treated with preoperative chemoradiation therapy? . International Journal of Colorectal Disease .2012 ;(27):613-621

95. 2012 Hung CS,Lin SF,Liu HH,Kuo LJ,Li LT,Su HY, Liew PL, Lin FY, Wei PL, Liu DZ, Chang YJ.. Survivin-mediated Therapeutic Efficacy of Gemcitabine through Glucose-regulated Protein 78 in Hepatocellular Carcinoma . Ann Surg Oncol .2012 ;(8):2744-2752

96. 2012 Chang YJ,Huang YP,Li ZL,Chen CH. GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells . PLoS ONE .2012 ;(4):e35123

97. 2012 Hung CS,Liu HH,Huang MT,Cheng CW,Kuo LJ,Ho YS, Wu CH, Chen CM, Wei PL, Chang YJ. Knockdown survivin expression reduces the efficacy of curcumin treatment in hepatocellular carcinoma cells . Ann Surg Oncol .2012 ;(11):3547-55

98. 2012 Hung CS,Liu HH,Liu JJ,Yeh CT,Chang TC,Wu CH, Ho YS, Wei PL, Chang YJ. MicroRNA-200a and -200b Mediated Hepatocellular Carcinoma Cell Migration Through the Epithelial to Mesenchymal Transition Markers . Ann Surg Oncol .2012

99. 2012 Huang CY,Shih CM,Tsao NW,Chen YH,Li CY,Chang YJ, Chang NC, Ou KL, Lin CY, Lin YW, Nien CH, Lin FY. GroEL1, from Chlamydia pneumoniae, induces vascular adhesion molecule 1 expression by p37(AUF1) in endothelial cells and hypercholesterolemic rabbit . PLoS One .2012 ;(8):e42808

100. 2012 Huang CY,Lin FY,Shih CM,Au HK,Chang YJ,Nakagami H, Morishita R, Chang NC, Shyu KG, Chen JW. Moderate to high concentrations of high-density lipoprotein from healthy subjects paradoxically impair human endothelial progenitor cells and related angiogenesis by activating Rho-associated kinase pathways . Arterioscler Thromb Vasc Biol .2012 ;(10):2405-2417

101. 2012 Tai CJ,Wang CK,Chang YJ,Lin CS,Tai CJ. Aqueous Extract of Solanum nigrum Leaf Activates Autophagic Cell Death and Enhances Docetaxel-Induced Cytotoxicity in Human Endometrial Carcinoma Cells. . Evid Based Complement Alternat Med. .2012

102. 2011 Lin FY,Lin YW,Huang CY,Chang YJ,Tsao NW,Chang NC, Ou KL, Chen TL, Shih CM, Chen YH.. GroEL1, a Heat Shock Protein 60 of Chlamydia pneumoniae, Induces Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1 Expression in Endothelial Cells and Enhances Atherogenesis in Hypercholesterolemic Rabbits. . J immunology .2011 ;(7):4405-4414

103. 2011 Po-Li Wei,Shyr-Yi Lin,Yu-Jia Chang. Cigarette Smoking and Colorectal Cancer: From Epidemiology to Bench . Journal of Experimental & Clinical Medicine .2011 ;(6):257-261

104. 2011 Chin-Sheng Hung,Yu-Jin Peng,Po-Li Wei,Chia-Hwa Lee,Hou-Yu Su,Yuan-Soon Ho,Chih-Hsiung Wu,Yu-Jia Chang. The alpha9 Nicotinic Acetylcholine Receptor is the Key Mediator in Nicotine-enhanced Cancer Metastasis in Breast Cancer Cells . Journal of Experimental and Clinical Medicine .2011 ;(6):283-292

105. 2011 Kuo LJ,Hung CS,Wu CH,Wang W,Tam KW,Liang HH, Chang YJ, Wei PL. Oncological and Functional Outcomes of Intersphincteric Resection for Low Rectal Cancer. . Journal of surgical Research .2011 ;(1):93-98

106. 2011 Lien YC,Wang W,Kuo LJ,Liu JJ,Wei PL,Ho YS, Ting WC, Wu CH, Chang YJ.. Nicotine Promotes Cell Migration Through Alpha7 Nicotinic Acetylcholine Receptor in Gastric Cancer Cells. . Annals of surgical oncology .2011 ;(9):2671-2679

107. 2011 Chen CH,Chang YJ,Ku MSB,Chung KT,Yang JT. Enhancement of temozolomide-induced apoptosis by valproic acid in human glioma cell lines through the mechanisms of redox regulation . J Mol Med .2011 ;(3):303-315

108. 2011 Chang YJ,Tai CJ,Kuo LJ,Wei PL,Liang HH,Liu TZ, Wang W, Tai CJ, Ho YS, Wu CH, Huang MT.. Glucose-Regulated Protein 78 (GRP78) Mediated the Efficacy to Curcumin Treatment on Hepatocellular Carcinoma. . Annals of Surgical Oncology .2011 ;(8):2395-2403

109. 2011 Wei PL,Kuo LJ,Huang MT,Ting WC,Ho YS,Wang W, An J, Chang YJ. Nicotine enhances colon cancer cell migration by induction of fibronectin . Annals of Surgical Oncology .2011 ;(6):1782-1790

110. 2010 Lee CH,Huang CS,Chen CS,Tu SH,Wang YJ,Chang YJ, Tam KW, Wei PL, Cheng TC, Chu JS, Chen LC, Wu CH, Ho YS.. Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells. . J Natl Cancer Inst. .2010 ;(17):1322-1335

111. 2010 Chen CS,Lee CH,Hsieh CD,Ho CT,Pan MH,Huang CS, Tu SH, Wang YJ, Chen LC, Chang YJ, Wei PL, Yang YY, Wu CH, Ho YS.. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins. . Breast Cancer Res Treat. .2010 ;(1):73-87

112. 2010 Chang YJ,Chiu CC,Wu CH,An J,Wu CC,Liu TZ, Wei PL, Huang MT.. Glucose-Regulated Protein 78 (GRP78) Silencing Enhances Cell Migration but Does Not Influence Cell Proliferation in Hepatocellular Carcinoma. . Ann Surg Oncol. .2010 ;(6):1703-1709

113. 2010 Chiou JF, Tai CJ,Huang MT,Wei PL,Wang YH,An J,Wu CH, Liu TZ, Chang YJ. Glucose-regulated protein 78 is a novel contributor to acquisition of resistance to sorafenib in hepatocellular carcinoma. . Ann Surg Oncol .2010 ;(2):603-612

114. 2010 Huang MT,Wei PL,Liu JJ,Huang HC,An J,Wu CC, Wu CH, Yang YY, Chang YJ. Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression. . Annals of surgical oncology .2010 ;(12):3379-3385

115. 2010 Chen MF,Chen WC,Chang YJ,Wu CF,Wu CT. Role of DNA methyltransferase 1 in hormone-resistant prostate cancer. . J Mol Med. .2010 ;(9):953-962

116. 2010 Tu SH,Ku CY,Ho CT,Chen CS,Huang CS,Lee CH, Chen LC, Pan MH, Chang HW, Chang CH, Chang YJ, Wei PL, Wu CH, Ho YS. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits nicotine- and estrogen-induced α9-nicotinic acetylcholine receptor upregulation in human breast cancer cells . Mol Nutr Food Res .2010 ;(3):455-466

117. 2010 Tung JN,Cheng YW,Hsu CH,Liu TZ,Hsieh PY,Ting LL, Ko HL, Chang YJ, Chiou JF, Wu AT. Normoxically overexpressed hypoxia inducible factor 1-alpha is involved in arsenic trioxide resistance acquisition in hepatocellular carcinoma . Ann Surg Oncol .2010 ;(5):1492-1500

118. 2010 Lee CH,Chang YC,Chen CS,Tu SH,Wang YJ,Chen LC, Chang YJ, Wei PL, Chang HW, Chang CH, Huang CS, Wu CH, Ho YS. Crosstalk between nicotine and estrogen-induced estrogen receptor activation induces α9-nicotinic acetylcholine receptor expression in human breast cancer cells . Breast Cancer Res Treat .2010 ;(2):331-345

119. 2009 Wei PL,Chang YJ,Ho YS,Lee CH,Yang YY,Lin SY. Tobacco-specific carcinogen enhances colon cancer cell migration through alpha7-nicotinic acetylcholin receptor . Ann Surg .2009 ;(6):978-985

120. 2008 Chang PC,Chang YJ,Wu HL,Chang CW,Lin CI,Wang WC, Shi GY. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). . Thromb Haemost. 2008 Apr;99(4):729-38. .2008 ;(99):729-738

121. 2008 Chen LM,Wang RS,Lee YF,LiuNC,Chang YJ,Wu CC, Xia S, Hung YC, Chang C. Subfertility with Defective Folliculogenesis in Female Mice Lacking Testicular Orphan Nuclear Receptor 4 . Molecular Endocrineology .2008 ;(4):858-867

122. 2007 Yang Z, Chang YJ,,Miyamoto H,,Ni J,,Niu Y,,Chen Z,,Chen YL, Yao JL, di Sant'Agnese PA, Chang C.. Transgelin functions as a suppressor via inhibition of ARA54-enhanced androgen receptor transactivation and prostate cancer cell growth. . Molecular endocrinology .2007 ;(2):343-358

123. 2007 Miyamoto H,Yang Z,Chen YT,,Ishiguro H,,Uemura H,,Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Y. Promotion of bladder cancer development and progression by androgen receptor signals. . Journal of the National Cancer Institute .2007 ;(99):558-568

124. 2007 Yang Z, Chang YJ,Yu IC,,Yeh S,,Wu CC,,Miyamoto H,,Merry DE, Sobue G, Chen LM, Chang SS, Chang C.. ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. . Nature Medicine .2007 ;(3):348-353

125. 2006 Yang Z, Chang YJ,Miyamoto H,,Yeh S,Yao JL,,di Sant'Agnese PA,,Tsai MY, Chang C. Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54. . Endocrinology. .2006 ;(3):1340-1349

126. 2006 Zhang C, Yeh S,,Chen YT,,Wu CC,,Chuang KH,,Lin HY,,Wang RS, Chang YJ, Mendis-Handagama C, Hu L, Lardy. Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells. . Proc Natl Acad Sci U S A. .2006 ;(103):17718-17723

研究計畫

計畫名稱
113 探討CWH43調控細胞衰老通路在大腸直腸癌於化學及放射線治療的反應與臨床上應用(1/3)
補助單位
國家科學及技術委員會

計畫名稱
112 F3 Bromelain的輻射增敏效應--探索鳳 梨酵素在大腸直腸癌治療中的新角色
補助單位
國家科學及技術委員會

計畫名稱
109 探討 CWH43 大腸直腸癌發展的角色及其調控機制
補助單位
科技部

計畫名稱
108 探討溶質載體轉選蛋白B4(SLC35B4)在大腸直腸癌症發展的角色及其調控機制(3/3)
補助單位
科技部

計畫名稱
107 探討溶質載體轉選蛋白B4(SLC35B4)在大腸直腸癌症發展的角色及其調控機制(2/3)
補助單位
科技部

計畫名稱
106 探討溶質載體轉選蛋白B4(SLC35B4)在大腸直腸癌症發展的角色及其調控機制(1/3)
補助單位
科技部

計畫名稱
105 探討醣調節蛋白九十四在食道癌進行、轉移上的角色及機轉探討、藥物開發
補助單位

計畫名稱
103 探討maspin對於Gemcitabine在賀爾蒙不敏感性攝護腺癌治療上的角色及作用機制探討
補助單位
衛生福利部雙和醫院(委託臺北醫學大學興建經營)

計畫名稱
103 探討抗氧化物質對於肝癌細胞抗藥性及治療上的運用
補助單位
科技部

計畫名稱
103 探討alpha7尼古丁接受器在胃癌診斷及臨床治療上的角色(3/3)
補助單位
科技部

計畫名稱
102 探討alpha7尼古丁接受器在胃癌診斷及臨床治療上的角色(2/3)
補助單位
行政院國家科學委員會

計畫名稱
102 探討ALPHA7尼古丁接受器在胃癌診斷及臨床治療上的角色(2-3)
補助單位
科技部

計畫名稱
102 探討ALPHA7尼古丁接受器在胃癌診斷及臨床治療上的角色(3/3)
補助單位
科技部

計畫名稱
101 探討 GRP78 作為攝護腺癌化學治療之癒後因子之潛能
補助單位
臺北醫學大學附設醫院

計畫名稱
101 探討alpha7尼古丁接受器在胃癌診斷及臨床治療上的角色
補助單位
行政院國家科學委員會

計畫名稱
100 臨床抗癌中草藥與肺癌常用化療藥物結合處理下對人類肺癌細胞抑制效果之評估與分子抑癌機制探討
補助單位
奇美醫療財團法人奇美醫院

計畫名稱
99 ASC-J9抑制攝護腺癌的作用機制及ASC-J9在預防攝護腺癌發生上的效果
補助單位
行政院國家科學委員會

計畫名稱
98 alpha7尼古丁接受器在胃癌生長及轉移的機制
補助單位
衛生福利部雙和醫院(委託臺北醫學大學興建經營)

計畫名稱
98 尼古丁受體在肝癌發生轉移及再發的角色之探討
補助單位
臺北醫學大學附設醫院

計畫名稱
98 尼古丁接受器在肝癌轉移上的角色及機制探討
補助單位
臺北醫學大學附設醫院

計畫名稱
98 抗微生物胜酶defensin在大腸癌上的角色及治療上的研究
補助單位
臺北醫學大學附設醫院

計畫名稱
98 探討ASC-J9於攝護腺癌治療的效果及機轉
補助單位
行政院國家科學委員會

計畫名稱
96 Human umbilical cord blood (hUCB)-derived mesenchymal stem cells inhibited prostate cancer and liver cancer progression and metestatsis
補助單位
臺北醫學大學附設醫院

計畫名稱
96 探討ASC-J9於攝護腺癌治療的效果及機轉
補助單位
行政院國家科學委員會

計畫名稱
96 雄性激素接受器的作用蛋白質在抑制攝護腺癌生長上的角色研究
補助單位
臺北醫學大學新聘教師計畫

計畫名稱
95 雄性激素接受器和其作用的蛋白質在攝護腺腫瘤的角色
補助單位
行政院國家科學委員會